Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Incyte Corporation
Masonic Cancer Center, University of Minnesota
Baylor College of Medicine